Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients

被引：13
|
作者：
Zeuzem, Stefan [1 ]
机构：
[1] JW Goethe Univ Hosp, Dept Med 1, D-60590 Frankfurt, Germany
来源：
JOURNAL OF HEPATOLOGY | 2008年 / 49卷 / 02期
关键词：
D O I：
10.1016/j.jhep.2008.05.004
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：157 / 159
页数：3
相关论文
共 50 条
  • [1] Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients
    Lawitz, Eric
    Rodriguez-Torres, Maribel
    Muir, Andrew J.
    Kieffer, Tara L.
    McNair, Lindsay
    Khunvichai, Ariya
    McHutchison, John G.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 49 (02) : 163 - 169
  • [2] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C
    Rakov, NE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 259 - 260
  • [3] Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b
    Flisiak, Robert
    Kawazoe, Seiji
    Znoyko, Olga
    Assy, Nimer
    Gadano, Adrian
    Kao, Jia-Horng
    Lee, Kwan-Sik
    Zwirtes, Ricardo
    Portsmouth, Simon
    Dong, Yuping
    Xu, Dong
    Kumada, Hiromitsu
    Srinivasan, Subasree
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2016, 36 (11): : 635 - 643
  • [4] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C - Reply
    Fried, MW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 260 - 260
  • [5] Peginterferon alfa-2a in patients with chronic hepatitis C
    Zeuzem, S
    Feinman, SV
    Rasenack, J
    Heathcote, EJ
    Lai, MY
    Gane, E
    O'Grady, J
    Reichen, J
    Diago, M
    Lin, A
    Hoffman, J
    Brunda, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (23): : 1666 - 1672
  • [6] Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin
    Rustgi, V. K.
    Esposito, S.
    Hamzeh, F. M.
    Shiffman, M. L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (05) : 433 - 440
  • [7] Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or-2b to Patients With Chronic Hepatitis C
    Marcellin, Patrick
    Forns, Xavier
    Goeser, Tobias
    Ferenci, Peter
    Nevens, Frederik
    Carosi, Giampiero
    Drenth, Joost P.
    Serfaty, Lawrence
    De Backer, Koen
    Van Heeswijk, Rolf
    Luo, Donghan
    Picchio, Gaston
    Beumont, Maria
    [J]. GASTROENTEROLOGY, 2011, 140 (02) : 459 - U159
  • [8] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Hepatitis C
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (18): : 1808 - 1809
  • [9] Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis
    Heathcote, EJ
    Shiffman, ML
    Cooksley, WGE
    Dusheiko, GM
    Lee, SS
    Balart, L
    Reindollar, R
    Reddy, RK
    Wright, TL
    Lin, A
    Hoffman, J
    De Pamphilis, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (23): : 1673 - 1680
  • [10] A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C
    Flisiak, Robert
    Shiffman, Mitchell
    Arenas, Juan
    Cheinquer, Hugo
    Nikitin, Igor
    Dong, Yuping
    Rena, Khurram
    Srinivasan, Subasree
    [J]. PLOS ONE, 2016, 11 (10):
12345